Lyka Labs Ltd
Lyka Labs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Lyka Labs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Lyka Labs Ltd Share Price Chart
Lyka Labs Ltd Fundamentals
Traded Volume: 69,165
Market Cap(Cr): 301
Avg Traded Price 84.30
1 Year return -40.41%
Upper Circuit 89.4
Lower Circuit 79.1
P/E TTM 147.00
P/B Ratio 1.00
Traded Value(Cr) 58.36
EPS TTM 0.576
Book value 0.576
Dividend 0.00%
Lyka Labs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Lyka Labs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Lyka Labs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -5.07%
1M -10.50%
3M -15.61%
1Y -40.41%
YTD -48.94%
Lyka Labs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Lyka Labs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 22574.00
Day Before Yesterday 78952.00
1W Avg 43148.40
1M Avg 24538.52
3M Avg 27721.65
Lyka Labs Ltd Technical Details
Lyka Labs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 79
Support 2 74
Support 3 69
Pivot Point : 84
Resistance 1 89
Resistance 2 95
Resistance 3 100
Lyka Labs Ltd Corporate Actions
Lyka Labs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Lyka Labs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by LYKALABS
Bonus
No Bonus has been declared by LYKALABS
Splits
No Split has been declared by LYKALABS
Others
Rights No Rights has been declared by LYKALABS
Lyka Labs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Lyka Labs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Lyka Labs Ltd's relative performance and valuation against major competitors.
Stock Name Nectar Lifescience Ltd ₹14.80 (+4.45%) M. Cap (Cr) 3.32 1 Yr Return (%) -56.83% P/E (TTM) -0.92 PB Ratio 0.35
Stock Name Infinium Pharmachem Ltd ₹236.25 (-2.38%) M. Cap (Cr) 3.68 1 Yr Return (%) -25.94% P/E (TTM) 40.36 PB Ratio 5.20
Stock Name Brooks Laboratories Ltd ₹102.34 (-2.67%) M. Cap (Cr) 3.01 1 Yr Return (%) -26.19% P/E (TTM) 26.14 PB Ratio 4.83
Stock Name Lyka Labs Ltd ₹84.38 (+5.24%) M. Cap (Cr) 3.01 1 Yr Return (%) -40.41% P/E (TTM) 146.55 PB Ratio 3.04
Stock Name Zenotech Laboratories Ltd ₹48.79 (-3.04%) M. Cap (Cr) 2.98 1 Yr Return (%) -35.97% P/E (TTM) 96.61 PB Ratio 3.19
Stock Name Sat Kartar Shopping Ltd ₹185.85 (-1.09%) M. Cap (Cr) 2.93 1 Yr Return (%) NaN% P/E (TTM) 29.81 PB Ratio 13.64
Stock Name Aarey Drugs & Pharmaceuticals Ltd ₹92.67 (-2.01%) M. Cap (Cr) 2.63 1 Yr Return (%) +69.45% P/E (TTM) 73.33 PB Ratio 1.97
Lyka Labs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Lyka Labs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 3.27 Mar 2024 3.09 Mar 2023 6.87 Mar 2022 76.53 Mar 2021 5.75
PARTICULARS Investing Activities Mar 2025 -13.10 Mar 2024 -8.61 Mar 2023 6.77 Mar 2022 -4.33 Mar 2021 0.13
PARTICULARS Financing Activities Mar 2025 5.26 Mar 2024 2.71 Mar 2023 -20.33 Mar 2022 -63.35 Mar 2021 -7.75
PARTICULARS Net Cash Flow Mar 2025 -4.57 Mar 2024 -2.81 Mar 2023 -6.69 Mar 2022 8.85 Mar 2021 -1.88
Lyka Labs Ltd Shareholding Pattern
This shows the ownership breakdown of Lyka Labs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 58.16%
Public 40.99%
Other Institutions 0.65%
FII 0.17%
Mutual Funds 0.01%
About Lyka Labs Ltd
Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The Company is engaged in the development, manufacture and marketing of quality finished dosages. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification, it has invested in Relic Finance, a company carrying on the business of finance and merchant banking.A GOI-recognised Export House, it received the Certificate of Merit for its excellent export performance in 1993-94. In the same year, it received an award from CHEMEXCIL for its outstanding performance.During 1997-98, the company's administrative office & plant at tarapur has been awarded ISO 9002 certification for its quality management system by SGS Yarsley International Certification Services Limited, UK.The production carried out at Bombay has been shifted to Tarapur and Ankleshwar in the year 1999-2000, inorder to achieve economies of scale and better compliance. The company has assigned Trade Marks and transferred technical, marketing know-how and allied rights pertaining to some of its products.The Company's factory at Tarapur, re-commissioned production in March, 2013. It launched Glutathione Injection, a First Time in India formulation during 2012-13. It commissioned the production at Ankleshwar factory. During Financial Year 2013-14, the Company had floated a Wholly Owned Subsidiary Company namely Lyka Healthcare Limited to focus, develop and expand Domestic Marketing of Ethical Products. Its another subsidiary, Lyka Exports Limited reorganized its activities and resultant, it sold the Animal Healthcare Business in 2014. The subsidiaries, Lyka Healthcare Limited and Lyka Exports Limited merged with the Company which became effective from April 01, 2016. During the year 2021-22, IPCA together with persons acting in concert acquired 26.70% shares of the Company through Public Offer consisting a total shareholding of 27.76% of the Paid-up Equity Capital of the Company and resultant to acquisition in stake, became the Joint Promoters of Company.The Company has acquired the animal healthcare business of the Agilis Healthcare Private Limited in 2023. It launched Tofacitinib ointment in FY 2023. Company has ventured into Gynaecology and Assisted Reproductive Technology (ART) through its new division, FertiNova in FY 2025. It launched Lyophilised Injection, Liquid Injections & Dry Powder Injections; Topical Preparation for Ointment, Creams and Lotions in 2025.
Managing Director & CEO
KUNAL NARENDRA GANDHI
Registered office 4801/B & 4802/A, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002
FAX :91-02646-221422/220549
Background
Incorporation Year 1976
Face Value ₹10.00
Market Lot 1
FAQs on Lyka Labs Ltd
How to buy Lyka Labs Ltd shares on NSE?
To buy Lyka Labs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Lyka Labs Ltd share price today?
The Lyka Labs Ltd share price on NSE is ₹84.38 today.
What is the market cap of Lyka Labs Ltd on NSE?
The company has a market capitalization of ₹301.15.
What is the PE & PB ratio of Lyka Labs Ltd?
PE is 147 and PB is 1.
What is the 52 Week High and Low of Lyka Labs Ltd shares?
Lyka Labs Ltd stock price high: ₹176.59 Lyka Labs Ltd stock price low: ₹79.06.